Intellia Therapeutics Inc (NASDAQ:NTLA)

52.17
BATS BZX Real-Time Price
As of 1:41pm ET
 +0.40 / +0.77%
Today’s Change
37.08
Today|||52-Week Range
180.59
-55.88%
Year-to-Date

Stock Price Forecast

The 22 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 125.00, with a high estimate of 207.00 and a low estimate of 54.00. The median estimate represents a +139.60% increase from the last price of 52.17.

Analyst Recommendations

The current consensus among 24 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.28
Sales
$9.4M
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 34.55%
 
 
 
 
 
 
Growthannually -52.43%
 
 
 
 
 
 

Sales

Growthquarterly -16.34%
 
 
 
 
 
 
Growthannually 38.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.